Femasys

OverviewSuggest Edit

Femasys is a biomedical company that provides women’s healthcare solutions including minimally invasive and non-surgical product technologies. It offers two product candidates: FemBloc for permanent birth control and FemaSeed as an artificial insemination infertility treatment.

TypePublic
Founded2004
HQSuwanee, GA, US
Websitefemasys.com

Latest Updates

Employees (est.) (Jun 2021)28(+8%)
Revenue (FY, 2021)$1.2 M
Share Price (Aug 2022)$2.1
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Femasys

Kathy Lee-Sepsick

Kathy Lee-Sepsick

President & CEO
Lexy Kelley

Lexy Kelley

Vice President, Clinical & Medical Affairs
Show more

Femasys Office Locations

Femasys has an office in Suwanee
Suwanee, GA, US (HQ)
3950 Johns Creek Ct #100
Show all (1)

Femasys Financials and Metrics

Femasys Revenue

Femasys's revenue was reported to be $1.18 m in FY, 2021
USD

Revenue (Q1, 2022)

321.4k

Gross profit (Q1, 2022)

198.7k

Net income (Q1, 2022)

(2.9m)

EBIT (Q1, 2022)

(2.9m)

Market capitalization (4-Aug-2022)

24.8m

Closing stock price (4-Aug-2022)

2.1

Cash (31-Mar-2022)

21.8m
Femasys's current market capitalization is $24.8 m.
Annual
USDFY, 2021

Revenue

1.2m

Cost of goods sold

370.4k

Gross profit

809.3k

Sales and marketing expense

208.7k
Quarterly
USDQ2, 2021Q3, 2021Q1, 2022

Revenue

326.0k269.6k321.4k

Cost of goods sold

107.6k105.4k122.7k

Gross profit

218.4k164.2k198.7k

Sales and marketing expense

21.8k43.3k68.9k
Annual
USDFY, 2021

Cash

24.8m

Accounts Receivable

84.3k

Inventories

208.3k

Current Assets

25.6m
Quarterly
USDQ2, 2021Q3, 2021Q1, 2022

Cash

29.9m27.3m21.8m

Accounts Receivable

158.8k143.5k170.3k

Inventories

146.9k150.3k223.0k

Current Assets

31.0m28.3m22.7m
Annual
USDFY, 2021

Net Income

(7.5m)

Depreciation and Amortization

591.1k

Inventories

(77.4k)

Accounts Payable

(228.8k)
Quarterly
USDQ2, 2021Q3, 2021Q1, 2022

Net Income

(2.9m)(5.2m)(2.9m)

Depreciation and Amortization

304.8k449.2k144.2k

Inventories

(15.5k)(19.0k)(17.4k)

Accounts Payable

165.8k(237.4k)102.9k
USDQ2, 2021

Revenue/Employee

12.1k
Show all financial metrics

Femasys Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Femasys Online and Social Media Presence

Embed Graph

Femasys News and Updates

Femasys Inc. Announces Financial Results for the Second Quarter Ended June 30, 2022 and Provides Corporate Update

ATLANTA, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced financial results for the…

Femasys To Participate in Upcoming BTIG Biotechnology Conference

ATLANTA, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Company’s manage…

Femasys to Participate in the Women’s Health Panel Discussion Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, July 13th at 11 a.m. ET

ATLANTA, July 11, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Company has been…

Femasys Inc. Announces Existing Board Member Charles Larsen as Chairperson of the Board

Mr. Larsen brings over 40 years of medical device industry experience and skills strongly aligned with the Company’s strategy to strengthen corporate governance Mr. Larsen brings over 40 years of medical device industry experience and skills strongly aligned with the Company’s strategy to strengthen…

Femasys Inc. to Present at the LSX World Congress USA 2022

ATLANTA, June 15, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that President and Chief …
Show more

Femasys Frequently Asked Questions

  • When was Femasys founded?

    Femasys was founded in 2004.

  • Who are Femasys key executives?

    Femasys's key executives are Kathy Lee-Sepsick and Lexy Kelley.

  • How many employees does Femasys have?

    Femasys has 28 employees.

  • What is Femasys revenue?

    Latest Femasys annual revenue is $1.2 m.

  • What is Femasys revenue per employee?

    Latest Femasys revenue per employee is $42.1 k.

  • Who are Femasys competitors?

    Competitors of Femasys include Analytica, Guardian BirthCare and Sequel.

  • Where is Femasys headquarters?

    Femasys headquarters is located at 3950 Johns Creek Ct #100, Suwanee.

  • Where are Femasys offices?

    Femasys has an office in Suwanee.

  • How many offices does Femasys have?

    Femasys has 1 office.